Rusch Intermittent Urethral Catheters

K222279 · Teleflex Medical · EZC · Aug 29, 2022 · Gastroenterology, Urology

Device Facts

• Record ID: K222279
• Device Name: Rusch Intermittent Urethral Catheters
• Applicant: Teleflex Medical
• Product Code: EZC · Gastroenterology, Urology
• Decision Date: Aug 29, 2022
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 876.5130
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

These catheters are indicated for the routine drainage of urine from the bladder. These catheters are not intended or designed for indwelling use.

Device Story

Rusch Intermittent Urethral Catheters are tubular devices with a funnel connector used for routine bladder drainage. The device is inserted into the urethra to facilitate urine flow; it is not designed for indwelling use. The catheter is constructed from PVC and is available in sizes ranging from 10 Ch. to 24 Ch. The device is intended for use by healthcare professionals or patients for intermittent catheterization. It functions as a passive drainage conduit; no electronic or mechanical components are involved.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Tubular shaft with funnel connector; material: PVC; sizes: 10 Ch. to 24 Ch.; shaft is uncoated; passive drainage mechanism.

Indications for Use

Indicated for routine drainage of urine from the bladder in patients requiring intermittent catheterization. Not for indwelling use.

Regulatory Classification

Identification

A urological catheter and accessories is a flexible tubular device that is inserted through the urethra and used to pass fluids to or from the urinary tract. This generic type of device includes radiopaque urological catheters, ureteral catheters, urethral catheters, coudé catheters, balloon retention type catheters, straight catheters, upper urinary tract catheters, double lumen female urethrographic catheters, disposable ureteral catheters, male urethrographic catheters, and urological catheter accessories including ureteral catheter stylets, ureteral catheter adapters, ureteral catheter holders, ureteral catheter stylets, ureteral catheterization trays, and the gastro-urological irrigation tray (for urological use).

Predicate Devices

• Rusch Intermittent Urethral Catheters (K173596)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the seal of the Department of Health & Human Services. To the right of the seal is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, and the word "ADMINISTRATION" in a smaller font size below.

August 29, 2022

Teleflex Medical Kelly Breheim Sr. MDR Regulatory Project Manager 3015 Carrington Mill Blvd Morrisville, NC 27560

Re: K22279

Trade/Device Name: Rusch Intermittent Urethral Catheters Regulation Number: 21 CFR 876.5130 Regulation Name: Urological catheter and accessories Regulatory Class: Class II Product Code: EZC Dated: July 29, 2022 Received: July 29, 2022

## Dear Kelly Breheim:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

for

Jessica K. Nguyen, Ph.D. Assistant Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known)

K222279

Device Name Rusch Intermittent Urethral Catheters

Indications for Use (Describe)

These catheters are indicated for the routine drainage of urine from the bladder. These catheters are not intended or designed for indwelling use.

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW *

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Rusch Intermittent Urethral Catheters

# 510(k) SUMMARY

#### I. SUBMITTER

Teleflex Medical, Incorporated 3015 Carrington Mill Blvd Morrisville, NC 27560 USA

Phone: [phone] Fax: [phone]

Contact Person: Kelley Breheim, Sr. MDR Regulatory Project Manager Date Prepared: July 29, 2022

## II. DEVICE

| Trade Name: | Rusch Intermittent Urethral Catheter |
|----------------------|--------------------------------------|
| Classification Name: | Catheter, Coude |
| Product Code: | EZC |
| Regulation Number: | 876.5130 |
| Classification: | Class II |
| Review Panel: | Gastroenterology/Urology |

## III. PREDICATE DEVICES

Rusch Intermittent Urethral Catheters cleared in submission K173596

## IV. DEVICE DESCRIPTION

The Intermittent Urethral Catheters consist of a tubular shaft with attached funnel as the connecting device. PVC material used in the catheter. The product sizes range from 10 Ch. to 24 Ch. The device shaft is uncoated.

## V. INDICATIONS FOR USE

These catheters are indicated for use for the routine drainage of urine from the bladder. These catheters are not intended or designed for indwelling use.

# VI. TECHNOLOGICAL CHARACTERISTICS COMPARISON TO THE PREDICATE DEVICE

This submission only affects the labeling of these products by adding contraindications to the IFUs. There were no modifications made to the Rusch Intermittent Urethral Catheters.